Oncotarget

Research Papers:

Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways

Yu-Long Lan, Xun Wang, Jin-Shan Xing, Zhen-Long Yu, Jia-Cheng Lou, Xiao-Chi Ma and Bo Zhang _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:88488-88500. https://doi.org/10.18632/oncotarget.19691

Metrics: PDF 685 views  |   HTML 1375 views  |   ?  


Abstract

Yu-Long Lan1,2,3,4,*, Xun Wang1,2,*, Jin-Shan Xing1, Zhen-Long Yu3, Jia-Cheng Lou1, Xiao-Chi Ma3 and Bo Zhang1

1Department of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China

2Department of Neurosurgery, The Third People’s Hospital of Dalian, Non-Directly Affiliated Hospital of Dalian Medical University, Dalian 116033, China

3Department of Pharmacy, Dalian Medical University, Dalian 116044, China

4Department of Physiology, Dalian Medical University, Dalian 116044, China

*These authors have contributed equally to this work

Correspondence to:

Bo Zhang, email: zhangbodl@126.com

Xiao-Chi Ma, email: maxc1978@163.com

Keywords: dopamine, glioma, mitochondrial apoptotic pathway, inflammation, growth

Received: March 01, 2017    Accepted: July 06, 2017    Published: July 29, 2017

ABSTRACT

Despite the emergence of innovative cancer treatment strategies, the global burden imposed by malignant glioma is expected to increase; thus, new approaches for treating the disease are urgently required. Dopamine, a monoamine catecholamine neurotransmitter, is currently regarded as an important endogenous regulator of tumor growth. Dopamine may play an important role in glioma treatment; however, the mechanism underlying the anti-tumor activity of dopamine remains poorly understood. Here, we explored the potential roles of dopamine in glioma and highlight the importance of endogenous regulators of tumor growth. We report that dopamine inhibited glioma cell proliferation. We investigated the biological functions of dopamine via migration, colony formation and apoptosis assays in glioma cells. We also evaluated cytochrome c release from the mitochondria and p50 and p65 subcellular localization by fluorescence microscopy. We performed western blotting and real-time quantitative polymerase chain reaction to detect apoptosis and inflammatory marker protein and gene expression levels, respectively. NF-κB p50/p65 nuclear localization was analyzed after U87MG and U251 cells were treated with dopamine. The in vivo anti-tumor efficacy of dopamine was also analyzed in xenograft mice. Taken together, our results indicated that dopamine induced apoptosis by activating the cytochrome c and caspase-dependent apoptotic pathway. Moreover, dopamine markedly down-regulated inflammation-related protein expression levels and p50/p65 NF-κB nuclear localization in tumor cells, thereby inhibiting increases in tumor weight and size in xenograft mice. Thus, therapies targeting the mitochondrial apoptotic and anti-inflammatory signaling pathways regulated by dopamine may represent promising treatments for human glioma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 19691